D-1433-2012 Class II Terminated

Recalled by Bayer HealthCare Pharmaceuticals Inc. — Wayne, NJ

FDA drug recall D-1433-2012 was initiated by Bayer HealthCare Pharmaceuticals Inc. on May 8, 2012 and is designated Class II. Reason for recall: Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product. The recall status is terminated (terminated Dec 18, 2012). Affected quantity: 112.295 kg.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2012
Initiation Date
May 8, 2012
Termination Date
Dec 18, 2012
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
112.295 kg

Product description

Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.

Reason for recall

Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.

Distribution pattern

Kansas and California.

Code information

Lot Number: 81202450, Exp 06/15/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1433-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1433-2012. Report a data issue: hello@regdatalab.com.